These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 28363951)

  • 1. Heterotrimeric G proteins in the control of parathyroid hormone actions.
    Bastepe M; Turan S; He Q
    J Mol Endocrinol; 2017 May; 58(4):R203-R224. PubMed ID: 28363951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of β-catenin binding to parathyroid hormone (PTH) receptor inhibits PTH-stimulated ERK1/2 activation.
    Yang Y; Wang B
    Biochem Biophys Res Commun; 2015 Aug; 464(1):27-32. PubMed ID: 26047699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The G protein α subunit variant XLαs promotes inositol 1,4,5-trisphosphate signaling and mediates the renal actions of parathyroid hormone in vivo.
    He Q; Zhu Y; Corbin BA; Plagge A; Bastepe M
    Sci Signal; 2015 Aug; 8(391):ra84. PubMed ID: 26307011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy.
    Sinha P; Aarnisalo P; Chubb R; Poulton IJ; Guo J; Nachtrab G; Kimura T; Swami S; Saeed H; Chen M; Weinstein LS; Schipani E; Sims NA; Kronenberg HM; Wu JY
    J Biol Chem; 2016 Jan; 291(4):1631-1642. PubMed ID: 26598522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways.
    Cupp ME; Nayak SK; Adem AS; Thomsen WJ
    J Pharmacol Exp Ther; 2013 Jun; 345(3):404-18. PubMed ID: 23516330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23.
    Sapir-Koren R; Livshits G
    Biofactors; 2014; 40(6):555-68. PubMed ID: 25352227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor and the signal transduction].
    Amizuka N; Li M
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():278-83. PubMed ID: 16279648
    [No Abstract]   [Full Text] [Related]  

  • 8. Parathyroid hormone.
    Leung EKY
    Adv Clin Chem; 2021; 101():41-93. PubMed ID: 33706890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare genetic disorders that impair parathyroid hormone synthesis, secretion, or bioactivity provide insights into the diagnostic utility of different parathyroid hormone assays.
    Höppner J; Jüppner H
    Curr Opin Nephrol Hypertens; 2024 Jul; 33(4):375-382. PubMed ID: 38701324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Nomenclature of Pseudohypoparathyroidism: Inactivating Parathyroid Hormone/Parathyroid Hormone-Related Protein Signaling Disorder.
    Turan S
    J Clin Res Pediatr Endocrinol; 2017 Dec; 9(Suppl 2):58-68. PubMed ID: 29280743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive Development of PTH Resistance in Patients With Inactivating Mutations on the Maternal Allele of GNAS.
    Usardi A; Mamoune A; Nattes E; Carel JC; Rothenbuhler A; Linglart A
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1844-1850. PubMed ID: 28323910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of ligand binding to the parathyroid hormone (PTH)/PTH-related protein receptor: selectivity of a modified PTH(1-15) radioligand for GalphaS-coupled receptor conformations.
    Dean T; Linglart A; Mahon MJ; Bastepe M; Jüppner H; Potts JT; Gardella TJ
    Mol Endocrinol; 2006 Apr; 20(4):931-43. PubMed ID: 16339275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D and dexamethasone inversely regulate parathyroid hormone-induced regulator of G protein signaling-2 expression in osteoblast-like cells.
    Hömme M; Schmitt CP; Himmele R; Hoffmann GF; Mehls O; Schaefer F
    Endocrinology; 2003 Jun; 144(6):2496-504. PubMed ID: 12746312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phosphocalcic metabolism: regulation and explorations].
    Courbebaisse M; Souberbielle JC
    Nephrol Ther; 2011 Apr; 7(2):118-38. PubMed ID: 21273150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudohypoparathyroidism type 1B caused by methylation changes at the GNAS complex locus.
    Poradosu S; Bravenboer B; Takatani R; Jüppner H
    BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27170606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTH, FGF-23, Klotho and Vitamin D as regulators of calcium and phosphorus: Genetics, epigenetics and beyond.
    Portales-Castillo I; Simic P
    Front Endocrinol (Lausanne); 2022; 13():992666. PubMed ID: 36246903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrestins in bone.
    Bohinc BN; Gesty-Palmer D
    Prog Mol Biol Transl Sci; 2013; 118():335-58. PubMed ID: 23764060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salt inducible kinases and PTH1R action.
    Yoon SH; Tang CC; Wein MN
    Vitam Horm; 2022; 120():23-45. PubMed ID: 35953111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in the PTH pathway and bone phenotypes in elderly women: evaluation of PTH, PTHLH, PTHR1 and PTHR2 genes.
    Tenne M; McGuigan F; Jansson L; Gerdhem P; Obrant KJ; Luthman H; Akesson K
    Bone; 2008 Apr; 42(4):719-27. PubMed ID: 18280230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous ligand recognition and structural transition of a human PTH receptor.
    Kobayashi K; Kawakami K; Kusakizako T; Miyauchi H; Tomita A; Kobayashi K; Shihoya W; Yamashita K; Nishizawa T; Kato HE; Inoue A; Nureki O
    Mol Cell; 2022 Sep; 82(18):3468-3483.e5. PubMed ID: 35932760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.